Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
- 16 August 2003
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 362 (9383), 504-505
- https://doi.org/10.1016/s0140-6736(03)14149-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Do editors live up to the Sept 10, 2001, expectations?The Lancet, 2002
- Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery.The Lancet, 2002
- The Potential Role of Fondaparinux as Venous Thromboembolism Prophylaxis After Total Hip or Knee Replacement or Hip Fracture SurgeryArchives of Internal Medicine, 2002
- Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind StudiesArchives of Internal Medicine, 2002
- Fondaparinux: a new synthetic pentasaccharide for thrombosis preventionThe Lancet, 2002
- Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonThe Lancet, 2002
- Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialThe Lancet, 2002
- Prevention of Venous Thromboembolism with FondaparinuxThe New England Journal of Medicine, 2002
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture SurgeryThe New England Journal of Medicine, 2001
- Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee SurgeryThe New England Journal of Medicine, 2001